MD679F1 - Inclusion complex of N-ethoxycarbonyl-3-morpholinsydnonimine or salts thereof with cyclodextrin or its derivatives, preparation thereof and pharmaceutical compositions containing them, method of preparation thereof and treatment method - Google Patents
Inclusion complex of N-ethoxycarbonyl-3-morpholinsydnonimine or salts thereof with cyclodextrin or its derivatives, preparation thereof and pharmaceutical compositions containing them, method of preparation thereof and treatment methodInfo
- Publication number
- MD679F1 MD679F1 MD94-0333A MD940333A MD679F1 MD 679 F1 MD679 F1 MD 679F1 MD 940333 A MD940333 A MD 940333A MD 679 F1 MD679 F1 MD 679F1
- Authority
- MD
- Moldova
- Prior art keywords
- preparation
- morpholinsydnonimine
- ethoxycarbonyl
- salts
- cyclodextrin
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 4
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 238000003801 milling Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention relates to the inclusion complex of N-ethoxycarbonyl-3-morpholinsydnonimine or salts thereof with cyclodextrin or its derivatives, preparation thereof and pharmaceutical compositions containing them, method of preparation thereof and treatment method. Inclusion complex of N-ethoxycarbonyl-3-morpholinsydnonimine or salts thereof with cyclodextrin or its derivatives are prepared by: a) interaction of N-ethoxycarbonyl-3-morpholinsydnonimine or salts thereof with cyclodextrin derivative into the solvent and extraction of the complex from the solution by dehydration or b) fast milling of N-ethoxycarbonyl-3-morpholinsydnonimine or salts thereof with cyclodextrin derivative.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU901868A HU210921B (en) | 1990-03-28 | 1990-03-28 | Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them |
| PCT/HU1991/000012 WO1991014680A1 (en) | 1990-03-28 | 1991-03-28 | Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD679F1 true MD679F1 (en) | 1997-02-28 |
| MD679G2 MD679G2 (en) | 1997-11-30 |
Family
ID=10956592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD94-0333A MD679G2 (en) | 1990-03-28 | 1994-08-25 | Inclusion complex of N-ethoxycarbonyl-3-morpholinsydnonimine or salts thereof with cyclodextrin or its derivatives, preparation thereof and pharmaceutical compositions containing them, method for preparation thereof and treatment method |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US5403840A (en) |
| EP (1) | EP0477315B1 (en) |
| JP (1) | JP2582497B2 (en) |
| KR (1) | KR950004705B1 (en) |
| CN (1) | CN1051080C (en) |
| AT (1) | ATE138656T1 (en) |
| AU (1) | AU638824B2 (en) |
| BG (1) | BG61689B1 (en) |
| BR (1) | BR9105136A (en) |
| CA (1) | CA2054188C (en) |
| CZ (1) | CZ287353B6 (en) |
| DE (1) | DE69119853T2 (en) |
| DK (1) | DK0477315T3 (en) |
| ES (1) | ES2090320T3 (en) |
| FI (1) | FI102460B1 (en) |
| GE (1) | GEP19991832B (en) |
| GR (1) | GR3020684T3 (en) |
| HR (1) | HRP920561B1 (en) |
| HU (1) | HU210921B (en) |
| IL (1) | IL97714A (en) |
| LT (1) | LT3394B (en) |
| LV (1) | LV10245B (en) |
| MC (1) | MC2185A1 (en) |
| MD (1) | MD679G2 (en) |
| NO (1) | NO179611C (en) |
| OA (1) | OA10029A (en) |
| PL (1) | PL165868B1 (en) |
| RO (1) | RO109649B1 (en) |
| RU (1) | RU2111216C1 (en) |
| SI (1) | SI9110908A (en) |
| SK (1) | SK279891B6 (en) |
| TJ (1) | TJ231R3 (en) |
| UA (1) | UA27226C2 (en) |
| WO (1) | WO1991014680A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA949182B (en) * | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
| GB2290964A (en) * | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
| US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| FR2805462B1 (en) * | 2000-02-24 | 2003-08-15 | Therabel Res | NEW ORAL GALENIC FORM WITH EXTENDED RELEASE OF MOLSIDOMINE |
| ITTO20120056A1 (en) * | 2012-01-24 | 2013-07-25 | Borla Ind | CONNECTOR FOR MEDICAL LINES OF INFUSION, TRANSFUSION AND THE LIKE |
| ITTO20130433A1 (en) * | 2013-05-29 | 2014-11-30 | Borla Ind | CONNECTOR FOR MEDICAL LINES |
| BE1028879B1 (en) | 2020-12-11 | 2022-07-12 | Europharmaceuticals | Molsidomine Sustained-Release Tablet |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1695897C3 (en) * | 1966-07-04 | 1979-02-15 | Takeda Chemical Industries Ltd | N-acyl-sydnonimines, their salts, processes for their preparation and medicaments containing these compounds |
| DE3221425A1 (en) * | 1982-06-07 | 1983-12-08 | Boehringer Ingelheim KG, 6507 Ingelheim | HYDROLYSIS-SENSITIVE ACTIVE SUBSTANCE CONTAINING STORAGE TABLET |
| DK243084A (en) * | 1983-05-26 | 1984-11-27 | Takeda Chemical Industries Ltd | PERCUTANEOUS PHARMACEUTICAL PREPARATIONS FOR EXTERNAL USE |
| DE3346614A1 (en) * | 1983-12-23 | 1985-07-04 | Anton Hummel Gmbh Metallwarenfabrik, 7808 Waldkirch | VENTILATION VALVE, IN PARTICULAR FOR VENTILATING HEATING SYSTEMS |
| GB8506792D0 (en) * | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
| DE3522191A1 (en) * | 1985-06-21 | 1987-01-15 | Cassella Ag | PHOTOSTABILIZATION OF SYDNONIMINES |
| GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| JPH0819004B2 (en) * | 1986-12-26 | 1996-02-28 | 日清製粉株式会社 | Sustained-release pharmaceutical preparation |
| IT1204725B (en) * | 1987-06-17 | 1989-03-10 | Edmond Pharma Srl | DIPYRIDAMOL INCLUSION COMPLEXES WITH CYCLODESTRINE |
| ES2037385T3 (en) * | 1988-01-14 | 1993-06-16 | Akzo N.V. | A MANUFACTURING PROCEDURE OF A PHARMACEUTICAL PREPARATION FOR LOCAL ADMINISTRATION. |
| US5120732A (en) * | 1988-06-14 | 1992-06-09 | Cassella Aktiengesellschaft | Substituted 3-aminosyndone imines, a process for their preparation and their use |
| IT1227626B (en) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | SUPPORTED DRUGS WITH INCREASED DISSOLUTION SPEED AND PROCEDURE FOR THEIR PREPARATION |
| SE8904296D0 (en) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | TRANSDERMAL SYSTEM |
| HU212730B (en) * | 1990-03-28 | 1996-10-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them |
-
1990
- 1990-03-28 HU HU901868A patent/HU210921B/en unknown
-
1991
- 1991-03-28 JP JP3507012A patent/JP2582497B2/en not_active Expired - Lifetime
- 1991-03-28 CN CN91102687A patent/CN1051080C/en not_active Expired - Fee Related
- 1991-03-28 MC MC@@@@D patent/MC2185A1/en unknown
- 1991-03-28 PL PL91293022A patent/PL165868B1/en unknown
- 1991-03-28 SK SK851-91A patent/SK279891B6/en unknown
- 1991-03-28 RO RO148827A patent/RO109649B1/en unknown
- 1991-03-28 DE DE69119853T patent/DE69119853T2/en not_active Expired - Lifetime
- 1991-03-28 EP EP91906726A patent/EP0477315B1/en not_active Expired - Lifetime
- 1991-03-28 CA CA002054188A patent/CA2054188C/en not_active Expired - Lifetime
- 1991-03-28 SI SI9110908A patent/SI9110908A/en unknown
- 1991-03-28 CZ CS1991851A patent/CZ287353B6/en not_active IP Right Cessation
- 1991-03-28 KR KR1019910701670A patent/KR950004705B1/en not_active Expired - Fee Related
- 1991-03-28 AT AT91906726T patent/ATE138656T1/en not_active IP Right Cessation
- 1991-03-28 ES ES91906726T patent/ES2090320T3/en not_active Expired - Lifetime
- 1991-03-28 AU AU75745/91A patent/AU638824B2/en not_active Expired
- 1991-03-28 US US07/807,852 patent/US5403840A/en not_active Expired - Lifetime
- 1991-03-28 RU SU5010581A patent/RU2111216C1/en active
- 1991-03-28 BR BR919105136A patent/BR9105136A/en not_active Application Discontinuation
- 1991-03-28 UA UA5010581A patent/UA27226C2/en unknown
- 1991-03-28 DK DK91906726.4T patent/DK0477315T3/en active
- 1991-03-28 IL IL9771491A patent/IL97714A/en not_active IP Right Cessation
- 1991-03-28 WO PCT/HU1991/000012 patent/WO1991014680A1/en not_active Ceased
- 1991-11-08 OA OA60094A patent/OA10029A/en unknown
- 1991-11-26 FI FI915569A patent/FI102460B1/en active
- 1991-11-27 BG BG95531A patent/BG61689B1/en unknown
- 1991-11-27 NO NO914649A patent/NO179611C/en not_active IP Right Cessation
-
1992
- 1992-09-28 HR HRP-908/91A patent/HRP920561B1/en not_active IP Right Cessation
- 1992-12-30 LV LVP-92-590A patent/LV10245B/en unknown
-
1993
- 1993-03-05 LT LTIP386A patent/LT3394B/en not_active IP Right Cessation
- 1993-06-16 GE GEAP1993884A patent/GEP19991832B/en unknown
-
1994
- 1994-08-25 MD MD94-0333A patent/MD679G2/en not_active IP Right Cessation
- 1994-11-28 TJ TJ94000007A patent/TJ231R3/en unknown
-
1996
- 1996-07-31 GR GR960402042T patent/GR3020684T3/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0214647A3 (en) | Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes | |
| NO952151L (en) | Injectable taxane derivative based preparations | |
| ES8403724A1 (en) | Process for the preparation of polysaccharide-protein complexes from bacterial envelopes, products obtained and immunogenic compostions containing them. | |
| IL89503A0 (en) | Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof | |
| IL90435A (en) | 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| HUT49600A (en) | Process for producing substituted flavonoid deriatives and salts, thereof, as well as pharmaceutical compositions comprising such compounds | |
| NL980012I2 (en) | Mometasone furoate monohydrate, preparation method and pharmaceutical compositions. | |
| DE2862384D1 (en) | O-substituted (+)-cyanidan-3-ol derivatives, method for their preparation, as well as pharmaceutical compositions containing these compounds and their preparation | |
| DK0422497T3 (en) | Inclusion complexes with Silybinin, their preparation of pharmaceutical preparations containing them | |
| MD679F1 (en) | Inclusion complex of N-ethoxycarbonyl-3-morpholinsydnonimine or salts thereof with cyclodextrin or its derivatives, preparation thereof and pharmaceutical compositions containing them, method of preparation thereof and treatment method | |
| ES475633A1 (en) | 1-N-substituted-4,6-di-O-(aminoglycosyl)-1,3-diamino-cyclitol derivatives, process for preparing them and medicaments containing them. | |
| FI875719A7 (en) | Novel alkanesulfonanilide derivatives, a process for their preparation and pharmaceutical compositions containing them. | |
| HUT50775A (en) | Process for producing disubstituted pyridine derivatives and pharmaceutical compositions containing them as active components | |
| NL192387B (en) | Pure Silibinine Derivatives, Process for Their Preparation and Pharmaceutical Preparation Containing Such Derivative. | |
| MD776C2 (en) | Inclusion complexes of 3-morpholinesydnonimine or its salts, or its tautomeric isomer with cyclodextrine or its derivatives, method for preparation thereof, pharmaceutical composition thereof, method for preparation thereof and for treatment of stenocardia or ishemic desease | |
| FI883392A7 (en) | Soluble derivatives of silybin, a process for their preparation and pharmaceutical compositions containing them. | |
| FR2676445B1 (en) | SUBSTITUTED PYRIDONE AMINO ACID AZETIDINYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS. | |
| GB2006193A (en) | Inclusion complexes of prostacyclin and its derivatives, their preparation and pharmaceutical compositions containing them | |
| IE37690L (en) | Pharmaceutical compositions containing eburnane derivatives | |
| IL59295A (en) | Dehydrophenylalanyl-tryptophan derivatives,their production and pharmaceutical compositions containing them | |
| AU4347389A (en) | Novel s-timolol derivative and process for its preparation | |
| GB1409149A (en) | Quecetin derivatives and pharmaceutical uses thereof | |
| ZA919224B (en) | Process for preparing taxane derivatives,new derivatives obtained and pharmaceutical compositions containing them | |
| ATE293635T1 (en) | STREPTOGRAMINE DERIVATIVES, THEIR PRODUCTION AND PREPARATIONS CONTAINING THEM | |
| YU48415B (en) | PROCEDURE FOR OBTAINING PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING CEPHALOSPORIN AND XANTINE DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC3A | Transfer or assignment (patent for invention) |
Free format text: 19970812 TERABEL INDUSTRIES S.A., FR |
|
| IF99 | Valid patent on 19990615 |
Free format text: EXPIRES: 20110328 |
|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |